These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 12875601)
1. Sentinel lymph node biopsy in patients with early-stage breast cancer: status of the National Clinical Trials. Wilke LG; Giuliano A Surg Clin North Am; 2003 Aug; 83(4):901-10. PubMed ID: 12875601 [TBL] [Abstract][Full Text] [Related]
2. Update on the NSABP and ACOSOG breast cancer sentinel node trials. White RL; Wilke LG Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950 [TBL] [Abstract][Full Text] [Related]
3. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA. Ross MI Ann Surg Oncol; 2001 Oct; 8(9 Suppl):77S-81S. PubMed ID: 11599908 [TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
5. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295 [TBL] [Abstract][Full Text] [Related]
6. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms. Gipponi M Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921 [TBL] [Abstract][Full Text] [Related]
7. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP Breast J; 2005; 11(5):338-43. PubMed ID: 16174155 [TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996 [TBL] [Abstract][Full Text] [Related]
9. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Yegiyants S; Romero LM; Haigh PI; DiFronzo LA Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977 [TBL] [Abstract][Full Text] [Related]
10. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958 [TBL] [Abstract][Full Text] [Related]
11. [Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases]. Meijer S; Torrenga H; van der Sijp JR Ned Tijdschr Geneeskd; 2002 May; 146(20):942-6. PubMed ID: 12051063 [TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846 [TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective. Catzeddu T; Bertelli G; Del Mastro L; Venturini M J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884 [TBL] [Abstract][Full Text] [Related]
14. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature. Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020 [TBL] [Abstract][Full Text] [Related]
15. Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer. Trocha SD; Giuliano AE Surg Oncol; 2003 Dec; 12(4):271-6. PubMed ID: 14998567 [TBL] [Abstract][Full Text] [Related]
16. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375 [TBL] [Abstract][Full Text] [Related]
18. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
19. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361 [TBL] [Abstract][Full Text] [Related]
20. Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Leidenius MH; Vironen JH; Heikkilä PS; Joensuu H Ann Surg Oncol; 2010 Jan; 17(1):254-62. PubMed ID: 19816743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]